Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group.

Sáez-Llorens, X; Castaño, E; Null, D; Steichen, J; Sánchez, P J; Ramilo, O; Top, F H; Connor, E

Sáez-Llorens, X; Castaño, E; Null, D; Steichen, J; Sánchez, P J; Ramilo, O; Top, F H; Connor, E.

Affiliation

Sáez-Llorens X; Department of Pediatrics, Infectious Diseases, Hospital del Niño, University of Panama School of Medicine, Panama City.

Pediatr Infect Dis J ; 17(9): 787-91, 1998 Sep.

Article in En | MEDLINE | ID: mdl-9779762

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Viruses / Bronchopulmonary Dysplasia / Respiratory Syncytial Virus Infections / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Humans / Infant / Newborn Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 1998 Document type: Article Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links